Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gurkirpal Singh

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|June 11, 2004
Understanding NSAID-PPI-COX-2 interrelationshipsGurkirpal Singh
Surgical Technology International|August 22, 2003
Treatment options for osteoarthritisGurkirpal Singh
Therapeutics and Clinical Risk Management|December 4, 2009
Celecoxib in arthritis: relative risk management profile and implications for patientsGayle McKellar, Gurkirpal Singh
Open Access Rheumatology : Research and Reviews|August 3, 2011
Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerationsMarina Scolnik, Gurkirpal Singh
Current Opinion in Rheumatology|April 5, 2008
Update on the use of analgesics versus nonsteroidal anti-inflammatory drugs in rheumatic disorders: risks and benefitsGayle McKellar, Rajan Madhok, Gurkirpal Singh
The American Journal of Medicine|July 6, 2004
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicamGurkirpal Singh, Stephan Lanes, George Triadafilopoulos
Digestive Diseases and Sciences|February 27, 2010
Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the USRamsey Cheung, Ajitha Mannalithara, Gurkirpal Singh
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2009
Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practiceGaurav Arora, Gurkirpal Singh, George Triadafilopoulos
Current Pain and Headache Reports|January 5, 2008
The problem with NSAIDs: what data to believe?Gayle McKellar, Rajan Madhok, Gurkirpal Singh
Rheumatology (Oxford, England)|June 7, 2019
Gout and hyperuricaemia in the USA: prevalence and trendsGurkirpal Singh, Bharathi Lingala, Alka Mithal
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Drugs of Today (Barcelona, Spain : 1998)|June 11, 2004
Understanding NSAID-PPI-COX-2 interrelationshipsGurkirpal Singh
Surgical Technology International|August 22, 2003
Treatment options for osteoarthritisGurkirpal Singh
Therapeutics and Clinical Risk Management|December 4, 2009
Celecoxib in arthritis: relative risk management profile and implications for patientsGayle McKellar, Gurkirpal Singh
Open Access Rheumatology : Research and Reviews|August 3, 2011
Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerationsMarina Scolnik, Gurkirpal Singh
Current Opinion in Rheumatology|April 5, 2008
Update on the use of analgesics versus nonsteroidal anti-inflammatory drugs in rheumatic disorders: risks and benefitsGayle McKellar, Rajan Madhok, Gurkirpal Singh
The American Journal of Medicine|July 6, 2004
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicamGurkirpal Singh, Stephan Lanes, George Triadafilopoulos
Digestive Diseases and Sciences|February 27, 2010
Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the USRamsey Cheung, Ajitha Mannalithara, Gurkirpal Singh
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2009
Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practiceGaurav Arora, Gurkirpal Singh, George Triadafilopoulos
Current Pain and Headache Reports|January 5, 2008
The problem with NSAIDs: what data to believe?Gayle McKellar, Rajan Madhok, Gurkirpal Singh
Rheumatology (Oxford, England)|June 7, 2019
Gout and hyperuricaemia in the USA: prevalence and trendsGurkirpal Singh, Bharathi Lingala, Alka Mithal
Pageof 6